1-1 of 1
Amy Meacham, M.S.
Close
Sort by
Journal Articles

AML Regression by Vascular Disruption with OXi4503 and Anti-Angiogenesis with Bevacizumab.

Gerard J Madlambayan, Ph.D., Amy Meacham, M.S., Koji Hosaka, Ph.D., Saad Mir, Marda Jorgensen, Edward W Scott, Ph.D., Dietmar W. Siemann, Ph.D., Christopher R. Cogle, M.D.
Journal: Blood
Blood (2009) 114 (22): 1031.
https://doi.org/10.1182/blood.V114.22.1031.1031
Published: 2009